Massachusetts Life Sciences Center Announces 2011 Small Business Matching Grant Program Awards

Featured In: Supplier News

Thursday, May 26, 2024

Get daily Bioscience Technology industry top stories and headlines - Sign up now!

newsvine diigo google
slashdot
Share
Loading...

The Massachusetts Life Sciences Center’s Board of Directors (“the Center”) today awarded $2 million in Small Business Matching Grants to four life sciences companies. Each company will receive $500,000 from the Center that matches federal small business grant funding that the companies have been awarded previously. The grants represent the second round of awards issued under the Center’s Small Business Matching Grant (“SBMG”) Program, established by the Life Sciences Act of 2008. Three companies received $1.5 million in grants through the Center’s first round of awards in May of 2010.

The Center’s Small Business Matching Grant Program, launched in January 2010 as part of the state’s ten-year, $1 billion Life Sciences Initiative, leverages federal small business grant funding that early-stage life sciences companies in the Commonwealth have received for their work in life sciences research and development, commercialization and manufacturing. Goals of the Center’s program include the creation of jobs inMassachusettsthrough the commercialization of products with high potential for market adoption and penetration.

To qualify for the program, companies must have received Phase II or Post-Phase II small business innovation research (“SBIR”) or small business technology transfer (“STTR”) grants from Federal agencies such as the National Institutes of Health (“NIH”), National Science Foundation (“NSF”), or Department of Defense (“DOD”). They also must qualify as a small business under the guidelines of the U.S Small Business Administration (“SBA”). A total of 32 companies applied for the current round of the program and the four recipients were chosen through a competitive process after extensive review by the Center’s peer review panel, Scientific Advisory Board, and Board of Directors. Descriptions of the four recipient companies are as follows:

  • Advantagene, Inc (Newton) – Advantagene, Inc. is a biopharmaceutical company focused on the development of a novel biologic immunotherapy to fight the recurrence of cancer. Their lead program is in Prostate cancer (Phase 3) with ProstAtak as the candidate. Based on results from Advantagene’s Phase 2 clinical study, ProstAtak may provide a three- to four-fold reduction in tumor recurrence, relative to current care.
  • Hepregen, Inc. (Medford) – Hepregen, Inc. is developing and commercializing HepatoPac, a bio-engineered micro-liver platform, for use in drug discovery and development. HepatoPac is a liver model that narrows the costly gap caused by poor correlation of preclinical data (i.e., animal and in vitro studies) and clinical observations. Utilizing HepatoPac, toxicity screening, mechanistic toxicology, identification of secondary metabolites, drug-drug interaction, and transporter/clearance studies can all be performed in vitro with increased confidence in the clinically-relevant predictive value.
  • Immunetics, Inc. (Boston) – Immunetics, Inc. is focused on the development, manufacture and distribution of tests for infectious diseases and pathogens, including for clinical diagnostic and blood screening applications. Immunetics currently markets FDA-approved tests for Lyme disease and anthrax, and other tests for HIV and parasitic diseases. These products are based on proprietary immunoassay technology. The company plans to launch BacTx in 2011, a unique rapid test for bacteria in blood products.
  • Reflectance Medical, Inc. (Westborough) – Reflectance Medical, Inc. is a noninvasive physiologic sensor company that enables physicians, healthcare professionals, first responders, medics, patients, other care givers and consumers to quickly assess a patient/user’s metabolic status so that timely feedback and/or suitable therapeutic interventions can be delivered, cost effectively and with confidence. Reflectance is currently focused on securing its 510(k) regulatory approvals to allow it to commence commercialization of the company’s CareGuide platform. Once that is established, the company will work on expanding its platform.

“Helping our life sciences companies grow is all about creating jobs,” said Governor Deval Patrick. “As we continue to strengthen our global leadership in the life sciences, the Center’s Small Business Matching Grant Program is meeting an important need and makingMassachusettsan even more attractive place for life sciences companies to locate and grow.”

“The SBMG program is another example of the Center’s leveraging strategy,” said Dr. Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center. “Federal SBIR/STTR grants provide Massachusetts companies with funds for their research and development; our SBMG program then provides the funds that companies need to bridge to commercialization. These four promising companies will bring cost-effective new treatments to the market and expand employment opportunities inMassachusetts. We are especially pleased that some of our grantees will contribute directly to the creation of biomanufacturing jobs in the Commonwealth.”

“The impact of the funding from the Center’s SBMG program has been very significant for Tetragenetics,” said R. Douglas Kahn, Chairman of Tetragenetics, a first-round grant recipient in 2010. “This new capital enabled the company to establish its corporate headquarters inMassachusettsand accelerate our vaccine and biotherapeutic development efforts by enabling our scientists to work together in a single lab for the first time.”

“The SBMG program is certainly recognized within the local early-stage biotechnology ecosystem as being a premier and very competitive program,” said John Reilly, Vice President of Business Development for Tetragenetics. “Having been awarded a grant is strong validation of Tetragenetics’ technology and market potential. That recognition has opened doors for our company to discussions with new Massachusetts-based strategic partners.”

“Small businesses are facing challenges and gaps with access to capital, and everyone agrees that job creation and development is critical to us emerging fully from the severe recession we have all experienced,” said Robert Nelson, Massachusetts District Director for the Small Business Administration. “The Small Business Matching Grant Program (SBMG) leverages on the strengths of theMassachusettseconomy and the federal funds our small businesses receive through the SBIR and STTR programs. The program will not only facilitate the creation of high quality manufacturing jobs, which are so critical at this stage of the economic recovery, but also will help the Commonwealth to achieve real economic development.”

Source: The Massachusetts Life Sciences Center

Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Bringing the Cell Image into Focus

Nov 2 2010

Improvements in transmission electron microscope (TEM) technology increase the power of this imaging tool for the study of cell biology.

Finding a Cure for Spinal Cord Injury with On-Demand LIMS

Oct 25 2010

The Miami Project to Cure Paralysis finds an on-demand laboratory information management system (LIMS) helps to accelerate discovery in its HCS projects.

Saving Cells: Image Processing for Improved Viability, Part II: Iterative Deconvolution

Oct 25 2010

3D light microscopy and deconvolution provide a means to investigate 3D structure, providing near-confocal quality images without the temporal requirements or potentially damaging phototoxicity associated with other 3D imaging technologies. This article is Part II in a series regarding viability, resolution improvement, and measurement in fluorescence imaging. Part I focused on spectral unmixing.

Saving Cells: Image Processing for Improved Viability

Sep 22 2010

This article is Part I of a two-part series regarding viability, resolution improvement, and measurement in fluorescence imaging. Part II will focus on deconvolution.

Evaluation of a New Nano-Type UV-Vis Spectrophotometer

Mar 3

Analysis of one- to four-microliter size samples for nucleic acids has become routine in many life science laboratories. However, until now, available instruments require considerable manipulation of the instrument and sample; some require manually recording the data. The user must typically lower and raise the arm manually, then wipe the sample manually from the target after each analysis. And fiberoptics used in some of these instruments are subject to deterioration.

Production of Recombinant Proteins and Monoclonal Antibodies in Hollow Fiber Bioreactors

Jan 25

While well-understood, robust and convenient, classical batch-style 2-D culture on non-porous supports or 3-D suspension culture in other devices are really not very biologically relevant models. Cell culture conditions can affect the quality of the antibody or protein produced.

Selecting Robots for Use in Drug Discovery and Testing

Dec 6 2010

Drug discovery and testing, with their need for speed, repeatability and verification, are ideally suited to benefit from robot automation. It is therefore not surprising that robots have been at the forefront of automation developments in both these areas.

HP Scalable Network Storage Systems for Life Sciences

Sep 13 2010

Life sciences research today is advancing exponentially, each step bringing us closer to the realization of truly personalized medicine–preventive care and treatments designed specifically for each individual. In the near future, PCPGM healthcare researchers expect to be able to use predictive genetic testing to create custom treatment plans for individuals and deliver dramatic improvements over today’s one-size-fits-all approach. But research capabilities are only part of the equation; current storage and operating capacities must also evolve to accommodate ever-expanding amounts of data before the goal of personalized medicine can be realized.

Using the Tecan Genesis Workstation to Automate a Cytometric Bead Array (CBA) Immunoassay

Mar 11 2010

The poster describe the process involved in automating a Cytometric Bead Array (CBA) immunoassay developed to measure relative concentrations of serum antibodies against Tetanus (TT), Sperm Whale Myoglobin (SWM) and Keyhole Limpet Hemocyanin (KLH) in KLH-immunized volunteers.

Ensuring Quality in Assays Performed with Automated Liquid Handlers

Feb 2 2010

The focus of this presentation is to highlight the need of ensuring quality in important assays performed with automated liquid handlers. Nearly all assays performed within a laboratory are volume-dependent. In turn, all concentrations of biological and chemical components in these assays, as well as the associated dilution protocols, are volume-dependent. Because analyte concentration is volume-dependent, an assay’s results might be falsely interpreted if liquid handler variability and inaccuracies are unknown or if the system(s) go unchecked for a long period.

Inkjet System for Protein Crystallography

Feb 1 2010

X-ray crystallography is used routinely by scientists to obtain the three dimensional structure of a biological molecule of interest.Such information can be used to determine how a pharmaceutical interacts with a protein target and what changes might improve functionality. However, the crystallization of macromolecules still remains a serious hindrance in structural determination despite impressive advances in screening methods and technologies.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9 2009

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Mortality after Fluid Bolus in African Children with Severe Infection.

6 hours ago

Background The role of fluid resuscitation in the treatment of children with shock and life-threatening infections who live in resource-limited settings is not established. Methods We randomly assigned children with severe febrile illness and impaired perfusion...

Is Biodegradability a Desirable Attribute for Discarded Solid Waste? Perspectives from a National Landfill Greenhouse Gas Inventory Model.

6 hours ago

There is increasing interest in the use of biodegradable materials because they are believed to be "greener". In a landfill, these materials degrade anaerobically to form methane and carbon dioxide. The fraction of the methane that is collected can be utilized...

Prokariotic Cell Collection in Denmark

Nov 6 2009

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16 2009

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
E-mail:   

MULTIMEDIA

Video:

Viewing SureFocus Slides

Jun 11 2010

A demonstration of SureFocus Microscope Slides in the review of AFB Smears. SureFocus Slides are a patent-pending breakthrough in tuberculosis detection, as their fluorescent staining circle remains visible during review, Fluorescence Microscopy.

Podcasts:

Allen Institute for Brain Research

Allen Institute for Brain Research

Oct 14 2009

Discussed in this interview are both the mouse brain project and the human cortex project with an emphasis on the importance of these projects to neuroscience research.

Top Stories and Headlines
EVERYDAY!

FREE Email Newsletter

Information: